Literature DB >> 1663185

Pathogenesis of human cytomegalovirus disease and the kidney.

J G Sissons1, J H Sinclair, L K Borysiewicz.   

Abstract

Uncertainty still surrounds many aspects of the pathogenesis of human cytomegalovirus (HCMV) infection. During asymptomatic infection HCMV is probably present in a small fraction of peripheral blood mononuclear cells (most likely monocytes); in active infection HCMV is detectable in a wider range of cells. In vitro experiments suggest that cellular control of transcription of HCMV immediate early (IE) gene expression is one key determinant of HCMV reactivation. The cytotoxic T cell response to IE and other virus gene products is probably important in subsequently limiting dissemination of HCMV infection. The basis for any association between active HCMV disease and allograft rejection is unclear, although homologies between cellular and viral proteins suggest possible mechanisms. Although HCMV may be associated with tubulointerstitial disease, there is no unequivocally established role for HCMV in the pathogenesis of human glomerular disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663185

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  3 in total

1.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

2.  Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.

Authors:  Lisa P Daley-Bauer; Grace M Wynn; Edward S Mocarski
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

3.  An iPSC-Derived Myeloid Lineage Model of Herpes Virus Latency and Reactivation.

Authors:  Emma Poole; Christopher J Z Huang; Jessica Forbester; Miri Shnayder; Aharon Nachshon; Baraa Kweider; Anna Basaj; Daniel Smith; Sarah Elizabeth Jackson; Bin Liu; Joy Shih; Fedir N Kiskin; K Roche; E Murphy; Mark R Wills; Nicholas W Morrell; Gordon Dougan; Noam Stern-Ginossar; Amer A Rana; John Sinclair
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.